Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

Nabriva Therapeutics (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious...

Wavefront Announces Second Quarter 2018 Financial Results

Wavefront Technology Solutions (TSXV:WEE), a global leader in the advancement of dynamic fluid injection technology for oil and gas well...

Alexco Reports Fourth Quarter and Year End 2017 Results

Alexco Resource Corp. (TSX:AXR,NYSE-American:AXU) today reports financial results for the fourth quarter and year ended December 31, 2017. All figures...

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based...

Novelion Therapeutics Announces Cost Reduction Plans and Capital Structure Review

Novelion Therapeutics (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases, today announced significant...

3D Signatures Reports First Quarter Financial Results for Fiscal 2018

3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based...

RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of neurologically controlled...